Overexpression of vascular endothelial growth factor (VEGF) in the retinal pigment epithelium leads to the development of choroidal neovascularization
- PMID: 10880384
- PMCID: PMC1850220
- DOI: 10.1016/S0002-9440(10)64525-7
Overexpression of vascular endothelial growth factor (VEGF) in the retinal pigment epithelium leads to the development of choroidal neovascularization
Erratum in
- Am J Pathol 2000 Oct;157(4):1413
Abstract
Vascular endothelial growth factor (VEGF) has been strongly implicated in the development of choroidal neovascularization found in age-related macular degeneration. Normally expressed in low levels, this study investigates whether the overexpression of VEGF in the retinal pigment epithelium is sufficient to cause choroidal neovascularization in the rat retina. A recombinant adenovirus vector expressing the rat VEGF(164) cDNA (AdCMV.VEGF) was constructed and injected into the subretinal space. The development of neovascularization was followed by fluorescein angiography, which indicates microvascular hyperpermeability of existing and/or newly forming blood vessels, and histology. VEGF mRNA was found to be overexpressed by retinal pigment epithelial cells and resulted in leaky blood vessels at 10 days postinjection, which was maintained for up to 31 days postinjection. By 80 days postinjection, new blood vessels had originated from the choriocapillaris, grown through the Bruch's membrane to the subretinal space, and disrupted the retinal pigment epithelium. This ultimately led to the formation of choroidal neovascular membranes and the death of overlying photoreceptor cells. By controlling the amount of virus delivered to the subretinal space, we were able to influence the severity and extent of the resulting choroidal neovascularization. These results show that even temporary overexpression of VEGF in retinal pigment epithelial cells is sufficient to induce choroidal neovascularization in the rat eye.
Figures





Similar articles
-
Choroidal neovascularization in the rat induced by adenovirus mediated expression of vascular endothelial growth factor.Invest Ophthalmol Vis Sci. 2000 Oct;41(11):3582-9. Invest Ophthalmol Vis Sci. 2000. PMID: 11006256
-
Intrachoroidal neovascularization in transgenic mice overexpressing vascular endothelial growth factor in the retinal pigment epithelium.Am J Pathol. 2001 Mar;158(3):1161-72. doi: 10.1016/S0002-9440(10)64063-1. Am J Pathol. 2001. PMID: 11238064 Free PMC article.
-
Expression of pigment epithelium-derived factor in normal adult rat eye and experimental choroidal neovascularization.Invest Ophthalmol Vis Sci. 2002 Apr;43(4):1168-75. Invest Ophthalmol Vis Sci. 2002. PMID: 11923262
-
Sensitivity of different vascular beds in the eye to neovascularization and blood-retinal barrier breakdown in VEGF transgenic mice.Adv Exp Med Biol. 2000;476:129-38. doi: 10.1007/978-1-4615-4221-6_11. Adv Exp Med Biol. 2000. PMID: 10949661 Review.
-
Vascular endothelial growth factor and ocular neovascularization.Am J Pathol. 1997 Jul;151(1):13-23. Am J Pathol. 1997. PMID: 9212726 Free PMC article. Review.
Cited by
-
Resistance to anti-VEGF therapy in neovascular age-related macular degeneration: a comprehensive review.Drug Des Devel Ther. 2016 Jun 2;10:1857-67. doi: 10.2147/DDDT.S97653. eCollection 2016. Drug Des Devel Ther. 2016. PMID: 27330279 Free PMC article. Review.
-
Controversial view of a genetically altered mouse model of focal retinal degeneration.Bioengineered. 2013 May-Jun;4(3):130-5. doi: 10.4161/bioe.22949. Epub 2012 Nov 29. Bioengineered. 2013. PMID: 23196746 Free PMC article.
-
Comparison of the efficacy of anti-VEGF monotherapy versus PDT and intravitreal anti-VEGF combination treatment in AMD: a Meta-analysis and systematic review.Int J Ophthalmol. 2016 Jul 18;9(7):1028-37. doi: 10.18240/ijo.2016.07.16. eCollection 2016. Int J Ophthalmol. 2016. PMID: 27500113 Free PMC article.
-
Lysosomal stress and lipid peroxidation products induce VEGF-121 and VEGF-165 expression in ARPE-19 cells.Graefes Arch Clin Exp Ophthalmol. 2011 Oct;249(10):1477-83. doi: 10.1007/s00417-011-1682-0. Epub 2011 Apr 21. Graefes Arch Clin Exp Ophthalmol. 2011. PMID: 21509530
-
RESVEGA, a Nutraceutical Omega-3/Resveratrol Supplementation, Reduces Angiogenesis in a Preclinical Mouse Model of Choroidal Neovascularization.Int J Mol Sci. 2021 Oct 13;22(20):11023. doi: 10.3390/ijms222011023. Int J Mol Sci. 2021. PMID: 34681683 Free PMC article.
References
-
- D’Amato RJ, Adamis AP: Angiogenesis inhibition in age-related macular degeneration. Ophthalmology 1995, 102:1261-1262 - PubMed
-
- Young RW: Pathophysiology of age-related macular degeneration. Surv Ophthalmol 1987, 31:291-306 - PubMed
-
- Amin R, Puklin JE, Frank RN: Growth factor localization in choroidal neovascular membranes of age-related macular degeneration. Invest Ophthalmol Vis Sci 1994, 35:3178-3188 - PubMed
-
- Frank RN: Growth factors in age-related macular degeneration: pathogenic and therapeutic implications. Ophthalmic Res 1997, 29:341-353 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources